0
Abstract: Slide Presentations |

IMPLEMENTATION OF A HOSPITAL-WIDE PLAN FOR REDUCTION OF VENTILATOR ASSOCIATED PNEUMONIA: ANALYSIS AND COST SAVINGS FREE TO VIEW

Alan J. Kanouff, DO*; Peter Kaplan, MD, FCCP; Bryan Veynovich, DO, FCCP; Gary Marrone, MD; Omer Bajwa, MD
Author and Funding Information

Allegheny General Hospital, Pittsburgh, PA


Chest


Chest. 2007;132(4_MeetingAbstracts):498. doi:10.1378/chest.132.4_MeetingAbstracts.498
Text Size: A A A
Published online

Abstract

PURPOSE: Ventilator associated pneumonia (VAP) occurs in 9-27% of all intubated patients. It is associated with a high attributable mortality and excessive hospital costs. Many strategies have been developed in an attempt to prevent VAP. We organized a VAP committee to review reported cases and developed hospital-wide protocols to reduce our occurrence of VAP.

METHODS: Allegheny General Hospital is a tertiary care, academic facility in Pittsburgh, PA with 778 beds including 120 critical care beds consisting of NICU, MICU, CCU, CTSICU, and a level 1 trauma ICU. In January 2004, a VAP committee consisting of physicians in Pulmonary/Critical Care and Infectious Diseases and an infection control team was organized to evaluate the hospitals VAP rate. Over the next two years, a series of pre-printed protocols were introduced hospital-wide. These included protocols on bag-valve-mask care, oral decontamination, yankauer suction devices, sedation, head of bed elevation, and ventilator weaning. Monthly audits were then performed to assess compliance. The VAP committee met monthly and reviewed all suspected cases. Total number of VAP cases were collected from January 1, 2004 to February 28, 2007. Hospital cost was also analyzed.

RESULTS: A total of 288 cases of VAP were prevented in the 38 month period with a total cost savings of $7.64 million. Our VAP rate decreased from 159 cases per year (10.0/1000 ventilator days) to an average of 68 per year (4.3/1000 ventilator days).

CONCLUSION: The formation of a VAP committee and adoption of hospital-wide protocols utilizing evidence-based prevention guidelines can result in a large reduction in VAP with considerable cost benefits.

CLINICAL IMPLICATIONS: Reducing VAP decreases morbidity in patients with presumed benefits in mortality along with considerable cost savings.

DISCLOSURE: Alan Kanouff, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543